Functionalized N,N-dialkylamino phenyl ethers and their method of use
Abstract:
Pharmaceutical compositions of the invention comprise functionalized N,N-dialkylamino phenyl ethers derivatives having a disease-modifying action in the treatment of diseases associated with lysosomal storage dysfunction that include Gaucher's disease, and any disease or condition involving lysosomal storage dysfunction.
Information query
Patent Agency Ranking
0/0